Acción A096530 SEEGENE, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Seegene, Inc.

Acciones

A096530

KR7096530001

Precio de cierre Korea S.E.
Otros sitios de cotización
 00:00:00 30/04/2024 		Varia. Cinco días. Varia. 1 de enero.
22.150 KRW -0,67 % Gráfico intradía de Seegene, Inc. +1,14 % -3,28 %
14/03 Seegene, Inc. informa de los resultados del ejercicio finalizado el 31 de diciembre de 2023 CI
24/01 Seegene Inc. anuncia su colaboración con Microsoft para hacer realidad un mundo libre de todas las enfermedades CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Seegene and UK Health Security Agency convene a summit to collectively realize 'a World Free from All Diseases'
Seegene and UK Health Security Agency convene a summit to collectively realize "a World Free from All Diseases"
Seegene and Springer Nature Announce Awardees for the Open Innovation Program
Seegene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Seegene Announces Collaboration with Microsoft to Realize 'a World Free from All Diseases'
Seegene Inc. Announces Collaboration with Microsoft to Realize a World Free from All Diseases
Seegene obtains ISO45001 certification
Microbix and Seegene USA Jointly Enhancing Lab Test Accuracy; Expanded Collaboration Aims To Improve Syndromic Infectious Disease Testing
Microbix Brief: Microbix and Seegene USA Jointly Enhancing Lab Test Accuracy
Seegene, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Seegene Earns Improved ESG Rating from the Korea Institute of Corporate Governance and Sustainability
Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on July 13, 2023.
Seegene Unveils 'Open Innovation Program Powered by Seegene' in Partnership with Springer Nature
Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on February 28, 2023.
Seegene, Inc.'s Equity Buyback announced on February 28, 2023, has expired with 2,046,354 shares, representing 4.11% for KRW 49,998.4 million.
Seegene, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Seegene Inc. Unveils Solutions to Popularize Molecular Diagnostics At 2023 AACC
Seegene, Inc. announces an Equity Buyback for KRW 30,000 million worth of its shares.
Seegene, Inc. authorizes a Buyback Plan.
Seegene, Inc. and Werfen Partner to Collaborate on Onesystem Business to Develop Syndromic qPCR Assays
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción A096530
  4. Noticias Seegene, Inc.
  5. Otros idiomas